Find Carbetocin Acetate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

NDC API

NDC API

0

VMF

NDC API

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Australia

Australia

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 37025-55-1, Pabal, Carbetocino, Carbetocinum, Chebi:59204, Lv-101
Molecular Formula
C45H69N11O12S
Molecular Weight
988.2  g/mol
InChI Key
NSTRIRCPWQHTIA-DTRKZRJBSA-N
FDA UNII
88TWF8015Y

Carbetocin Acetate
Carbetocin is a long-acting synthetic agonist analogue of human oxytocin, with antihemorrhagic and uterotonic activities. Upon administration, carbetocin targets, binds to and activates peripheral oxytocin receptors that are present on the smooth musculature of the uterus. This causes uterus contractions and prevents excessive bleeding after childbirth, particularly following Cesarean section, and may be used to decrease blood loss during hysteroscopic myomectomy.
1 2D Structure

Carbetocin Acetate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2S)-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]-1-[(3R,6S,9S,12S,15S)-6-(2-amino-2-oxoethyl)-9-(3-amino-3-oxopropyl)-12-[(2S)-butan-2-yl]-15-[(4-methoxyphenyl)methyl]-5,8,11,14,17-pentaoxo-1-thia-4,7,10,13,16-pentazacycloicosane-3-carbonyl]pyrrolidine-2-carboxamide
2.1.2 InChI
InChI=1S/C45H69N11O12S/c1-6-25(4)38-44(66)51-28(15-16-34(46)57)40(62)52-31(21-35(47)58)41(63)54-32(23-69-18-8-10-37(60)50-30(42(64)55-38)20-26-11-13-27(68-5)14-12-26)45(67)56-17-7-9-33(56)43(65)53-29(19-24(2)3)39(61)49-22-36(48)59/h11-14,24-25,28-33,38H,6-10,15-23H2,1-5H3,(H2,46,57)(H2,47,58)(H2,48,59)(H,49,61)(H,50,60)(H,51,66)(H,52,62)(H,53,65)(H,54,63)(H,55,64)/t25-,28-,29-,30-,31-,32-,33-,38-/m0/s1
2.1.3 InChI Key
NSTRIRCPWQHTIA-DTRKZRJBSA-N
2.1.4 Canonical SMILES
CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSCCCC(=O)NC(C(=O)N1)CC2=CC=C(C=C2)OC)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
2.1.5 Isomeric SMILES
CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSCCCC(=O)N[C@H](C(=O)N1)CC2=CC=C(C=C2)OC)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
2.2 Other Identifiers
2.2.1 UNII
88TWF8015Y
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 1-deamino-1-monocarba-2-(tyr(ome))-oxytocin

2. Dcomot

3. Depotocin

4. Oxytocin, 1-desamino-1-monocarba-(tyr(ome))(2)-

5. Oxytocin, 1-desamino-1-monocarba-(tyrosine(o-methyl))(2)-

2.3.2 Depositor-Supplied Synonyms

1. 37025-55-1

2. Pabal

3. Carbetocino

4. Carbetocinum

5. Chebi:59204

6. Lv-101

7. Carbetocinum [inn-latin]

8. Carbetocino [inn-spanish]

9. Deamino-2-o-methyltyrosine-1-carbaoxytocin

10. 1-butyric Acid-2-(3-(p-methoxyphenyl)-l-alanine)oxytocin

11. 88twf8015y

12. 1-butanoic Acid-2-(o-methyl-l-tyrosine)-1-carbaoxytocin

13. Fe 992097

14. Fe-992097

15. 7-pentaoxo-1-thia-4,7,10,13,16-pentazacycloicosane-3-carbonyl]pyrrolidine-2-carboxamide

16. C45h69n11o12s

17. (2s)-n-[(2s)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]-1-[(3r,6s,9s,12s,15s)-6-(2-amino-2-oxoethyl)-9-(3-amino-3-oxopropyl)-12-[(2s)-butan-2-yl]-15-[(4-methoxyphenyl)methyl]-5,8,11,14,1

18. Carbetocin [mi]

19. Carbetocin [inn]

20. Carbetocin [usan]

21. Carbetocin [mart.]

22. Carbetocin [who-dd]

23. Schembl39224

24. Carbetocin [usan:inn:ban]

25. Unii-88twf8015y

26. Chembl3301668

27. Gtpl11169

28. Dtxsid90897527

29. 1-carbaoxytocin, 1-butanoic Acid-2-(o-methyl-l-tyrosine)-

30. (2s)-n-[(2s)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]-1-[(3r,6s,9s,12s,15s)-6-(2-amino-2-oxoethyl)-9-(3-amino-3-oxopropyl)-12-[(2s)-butan-2-yl]-15-[(4-methoxyphenyl)methyl]-5,8,11,14,17-pentaoxo-1-thia-4,7,10,13,16-pentazacycloicosane-3-carbonyl]pyrrolidine-2-carboxamide

31. Who 5014

32. Einecs 253-312-6

33. Bdbm50044677

34. Mfcd01076600

35. Akos015994647

36. Zinc150338703

37. Db01282

38. Hs-2007

39. Ncgc00485451-02

40. Hy-17573

41. 025c551

42. A823503

43. Carbetocin 100 Microg/ml In Acetonitrile:methanol

44. Q5037853

45. 1-buttersaeure-2-(3-(4-methoxyphenyl)-l-alanin)oxytocin

46. 1-carboxytocin, 1-butanoic Acid-2-(o-methyl-l-tyrosine)-

47. Ethyl?2-chloro-4-(trifluoromethyl)pyrimidine-5-carboxylate

48. (2s)-2-{[(2s)-1-{[(3r,6s,9s,12s,15s)-12-[(2s)-butan-2-yl]-9-(2-carbamoylethyl)-6-(carbamoylmethyl)-15-[(4-methoxyphenyl)methyl]-5,8,11,14,17-pentaoxo-1-thia-4,7,10,13,16-pentaazacycloicosan-3-yl]carbonyl}pyrrolidin-2-yl]formamido}-n-(carbamoylmethyl)-4-methylpentanamide

49. 1-[6-(2-amino-2-oxo-ethyl)-9-(3-amino-3-oxo-propyl)-15-[(4-methoxyphenyl)methyl]-5,8,11,14,17-pentaoxo-12-sec-butyl-1-thia-4,7,10,13,16-pentazacycloicosane-3-carbonyl]-n-[1-[(2-amino-2-oxo-ethyl)carbamoyl]-3-methyl-butyl]pyrrolidine-2-carboxamide; 2,2,2-t;carbetocin

50. 1-{[(3r,6s,9s,12s,15s)-6-(2-amino-2-oxoethyl)-9-(3-amino-3-oxopropyl)-12-[(2s)-butan-2-yl]-15-(4-methoxybenzyl)-5,8,11,14,17-pentaoxo-1-thia-4,7,10,13,16-pentaazacycloicosan-3-yl]carbonyl}-l-prolyl-l-leucylglycinamide

51. Glycinamide, N-(4-mercapto-1-oxobutyl)-o-methyl-l-tyrosyl-l-isoleucyl-l-glutaminyl-l-asparaginyl-l-cysteinyl-l-prolyl-l-leucyl-, Cyclic (1->5)-thioether

52. O-methyl-n-(4-sulfanylbutanoyl)-l-tyrosyl-l-isoleucyl-l-glutaminyl-l-asparaginyl-l-cysteinyl-l-prolyl-l-leucyl-glycinamide Cyclic (1->5)-thioether

2.4 Create Date
2007-08-20
3 Chemical and Physical Properties
Molecular Weight 988.2 g/mol
Molecular Formula C45H69N11O12S
XLogP3-1.1
Hydrogen Bond Donor Count10
Hydrogen Bond Acceptor Count13
Rotatable Bond Count18
Exact Mass987.48478785 g/mol
Monoisotopic Mass987.48478785 g/mol
Topological Polar Surface Area388 Ų
Heavy Atom Count69
Formal Charge0
Complexity1850
Isotope Atom Count0
Defined Atom Stereocenter Count8
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Used to control postpartum hemorrhage and bleeding after giving birth.


5 Pharmacology and Biochemistry
5.1 Pharmacology

Carbetocin is a drug used to control postpartum hemorrhage, bleeding after giving birth. It is sold under the trade name Duratocin. It is an analogue of oxytocin, and its action is similar to that of oxytocin; it causes contraction of the uterus.


5.2 MeSH Pharmacological Classification

Delayed-Action Preparations

Dosage forms of a drug that act over a period of time by controlled-release processes or technology. (See all compounds classified as Delayed-Action Preparations.)


Oxytocics

Drugs that stimulate contraction of the myometrium. They are used to induce LABOR, OBSTETRIC at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. They may also be used alone or with other drugs to induce abortions (ABORTIFACIENTS). Oxytocics used clinically include the neurohypophyseal hormone OXYTOCIN and certain prostaglandins and ergot alkaloids. (From AMA Drug Evaluations, 1994, p1157) (See all compounds classified as Oxytocics.)


5.3 ATC Code

H - Systemic hormonal preparations, excl. sex hormones and insulins

H01 - Pituitary and hypothalamic hormones and analogues

H01B - Posterior pituitary lobe hormones

H01BB - Oxytocin and analogues

H01BB03 - Carbetocin


5.4 Absorption, Distribution and Excretion

Absorption

Bioavailability is 80% following intramuscular injection.


5.5 Biological Half-Life

40 minutes


5.6 Mechanism of Action

Carbetocin binds to oxytocin receptors present on the smooth musculature of the uterus, resulting in rhythmic contractions of the uterus, increased frequency of existing contractions, and increased uterine tone. The oxytocin receptor content of the uterus is very low in the non-pregnant state, and increases during pregnancy, reaching a peak at the time of delivery.


API SUPPLIERS

read-more
read-more

01

Rochem International Inc

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothRochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

Flag U.S.A
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Rochem

02

Omgene Life Sciences Pvt. Ltd

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOmgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Omgene Company Banner

03

Country

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Iran Expo
Not Confirmed
arrow

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Iran Expo
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

04

Jin Dun Medical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Iran Expo
Not Confirmed
arrow

05

Piramal Pharma Solutions

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Iran Expo
Not Confirmed
arrow

Piramal Pharma Solutions

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Iran Expo
Not Confirmed
USDMF CEP/COS JDMF EU-WCInactive-api NDC KDMF VMF Others AUDIT
blank

06

Ferring Pharmaceuticals

Switzerland

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Iran Expo
Not Confirmed
arrow

Ferring Pharmaceuticals

Switzerland

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Iran Expo
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

07

BCN Peptides

Spain

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Iran Expo
Not Confirmed
arrow

BCN Peptides

Spain

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Iran Expo
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF arrow-down VMF Others AUDIT
blank

08

ANHUI ANKE BIOTECHNOLOGY (GROUP) C...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Iran Expo
Not Confirmed
arrow

09

Hybio Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Iran Expo
Not Confirmed
arrow

10

Shenzhen JYMed Technology

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Iran Expo
Not Confirmed
arrow
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-moreread-more

01

Harbin Jixianglong Biotech Co Ltd

Country

USDMF

arrow
Arvo
Not Confirmed

01

Harbin Jixianglong Biotech Co Ltd

Country
arrow
Arvo
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 39953

Submission : 2024-05-29

Status : Active

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

KDMF

read-more
read-moreread-more

01

BCN Peptides

Spain
Arvo
Not Confirmed
arrow

BCN Peptides

Spain
arrow
Arvo
Not Confirmed

Carbetocin

Registrant Name : Samoh Pharmaceutical Co., Ltd.

Registration Date : 2019-01-17

Registration Number : 20190117-210-J-164

Manufacturer Name : BCN Peptides SA

Manufacturer Address : Pol. Ind. Els Vinyets-Els Fogars, II, 08777 Sant Quinti de Mediona, Barcelona Spain

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothRochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

Flag U.S.A
Digital Content Digital Content

Carbetocin Acetate

About the Company : Established in 1994, Rochem is a distributor of pharmaceutical, food, nutritional and animal health ingredients to some of the largest companies in the world. It sources high-quali...

Established in 1994, Rochem is a distributor of pharmaceutical, food, nutritional and animal health ingredients to some of the largest companies in the world. It sources high-quality ingredients manufactured in China. Headquartered in the Hauppauge, New York, Rochem has 16 offices spread across the globe to cater to the needs of its customers. Rochem’s operations are fully cGMP compliant and has been audited by the USFDA as well as several multinational organizations. It also trains and audits its partners to ensure all of their technologies and systems are FDA-compliant.
Rochem

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOmgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.

Flag India
Digital Content Digital Content

Carbetocin

About the Company : Omgene Life Sciences Private Limited is an R&D-driven biopharmaceutical company specializing in biopharmaceuticals, peptides, semi-synthetic, and synthetic actives. As a vertically...

Omgene Life Sciences Private Limited is an R&D-driven biopharmaceutical company specializing in biopharmaceuticals, peptides, semi-synthetic, and synthetic actives. As a vertically integrated company, we focus on developing high-quality formulations based on in-house-produced actives. With GMP-certified facilities and partnerships with contract manufacturers, we excel in formulation development for injectables, lyophilized injectables, complex generics, and oral peptide delivery systems, ensuring affordable, top-quality medicines.
Omgene Company Banner

03

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

carbetocin

About the Company : We, Anhui Anke Biotechnology (Group) Co., Ltd., professional and comprehensive in developing, producing and marketing pharmaceuticals concerning genetic engineering products,diagn...

We, Anhui Anke Biotechnology (Group) Co., Ltd., professional and comprehensive in developing, producing and marketing pharmaceuticals concerning genetic engineering products,diagnostic products,precision medicine, polypeptide APIs, biochemistry and traditional Chinese medicines,staffed with abount qualified and creative R&D team and equipped with first-class facilities, certified by GMP and ISO9001. Our parent company is located in China Hefei New and High Technology Development Area. As based on high-efficient Research & Development Center, we, AnkeBio always keep up with international development and have been undertaken with 10 subjects such as "National 863 Projects", National scientific and technological project, National key Torch Program and Scientific and Technological Projects, key scientific and technological specialties of Anhui province and Natural Fund Project and etc. and have developed nearly 10 National Novel Drugs in recent years. Our dominant products, Recombinant Human Growth Hormone (Ansomone®), Series of Recombinant Human Interferon alpha 2b (Anterferon®), MAR Kit for Anti-sperm Antibody and etc., are all developed independently. These products have more and more significant therapeutically effect on clinical testing and application of many kinds of intractable disease such as chronic hepatitis B, tumor, leukemia, nutritional support burned wound and immunopurification sterility and etc. Our subsidiary companies like Anhui Anke Yuliangqing Pharmaceutical Co., Ltd., Anhui Anke Hengyi Pharmaceutical Co., Ltd. and Anhui Anke Yuliangqing Pharmaceutical Co., Ltd have been established from recombination of Anqing Yuliangqing Pharmaceutical Co., Ltd.,Tongling NO.1 Pharmaceutical Company dominated by Anke biotechnology Co.,Ltd. since year 2000.The products are extended from biomedical products into modern Chinese herb medicines and synthetic medicines.
blank

04

Apino Pharma

China
Arvo
Not Confirmed
arrow

Apino Pharma

China
arrow
Arvo
Not Confirmed

Carbetocin Acetate

About the Company : Apino Pharma prides itself on being an innovation-driven company that strives to continuously improve its products and services. Our dedicated innovation team collaborates with the...

Apino Pharma prides itself on being an innovation-driven company that strives to continuously improve its products and services. Our dedicated innovation team collaborates with the world’s leading research institutes and universities to develop cutting-edge formulations and technologies that bring value to our customers. We are committed to exploring new opportunities presented by technology, science and global best practices to provide quality products and services that meet and exceed our customers’ needs.
blank

05

BCN Peptides

Spain
Arvo
Not Confirmed
arrow

BCN Peptides

Spain
arrow
Arvo
Not Confirmed

carbetocin

About the Company : BCN Peptides is a privately own company completely focused on the cGMP manufacture of Bioactive Peptides for Pharmaceutical and Veterinary applications. We are a customer oriented...

BCN Peptides is a privately own company completely focused on the cGMP manufacture of Bioactive Peptides for Pharmaceutical and Veterinary applications. We are a customer oriented organization focused on fulfilling the client’s needs at each stage of the their peptide drug development and lifecycle management. It also includes a team of dedicated and passionate scientists which help us to provide to our customer a scientific excellence in terms of synthetic peptide chemistry and analytical expertise. BCN Peptides has an excellent track record of successful inspections by Global Health Agencies (US FDA, EDQM, KFDA,…)
blank

06

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Carbetocin

About the Company : Ferring Pharmaceuticals is a research-driven, biopharmaceutical company devoted to identifying, developing and marketing innovative products in the fields of reproductive health, u...

Ferring Pharmaceuticals is a research-driven, biopharmaceutical company devoted to identifying, developing and marketing innovative products in the fields of reproductive health, urology, gastroenterology, endocrinology and orthopaedics. The company's research activities and products are connected by a common focus of providing tailored treatments that work on the body's own terms, enabling doctors to combat numerous diseases and medical conditions. Ferring has its own production facilities in several European countries and in South America, Israel and China. It is also currently building new facilities in the US and India.
blank

07

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Carbetocin Acetate

About the Company : Hybio is a hi-tech enterprise specializing in the R&D and manufacturing of diverse peptide products. Founded in 1998, after decades of effort, we have grown to be one of the larges...

Hybio is a hi-tech enterprise specializing in the R&D and manufacturing of diverse peptide products. Founded in 1998, after decades of effort, we have grown to be one of the largest and most professional peptide pharmaceutical companies in China. We were one of the first to enter the peptide pharmaceutical industry in China, and we are the only one that has a full range of peptide products and services, including peptide finished dosage products, peptide API products, and peptide CRO&CMO services.
blank

08

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Carbetocin Acetate

About the Company : JIN DUN Medical Research Institute is affiliated to Shanghai JIN DUN Industrial Co., Ltd., headquartered in Shanghai, adjacent to Hongqiao High-speed Railway Station and Hongqiao I...

JIN DUN Medical Research Institute is affiliated to Shanghai JIN DUN Industrial Co., Ltd., headquartered in Shanghai, adjacent to Hongqiao High-speed Railway Station and Hongqiao International airport. JIN DUN Medical Research Institute is committed to providing pharmaceutical intermediates and raw materials with the purpose of innovative drug research. Customized R&D and customized production services.
blank

09

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Carbetocin Acetate

About the Company : Piramal Pharma Solutions (PPS) is a CDMO that provides end-to-end solutions for drug development and manufacturing across the drug life cycle to its clients in North America, Europ...

Piramal Pharma Solutions (PPS) is a CDMO that provides end-to-end solutions for drug development and manufacturing across the drug life cycle to its clients in North America, Europe and Asia through a globally integrated network of facilities. It offers a range of services from drug discovery to commercial supply of APIs and finished dosage forms, along with specialized services like HPAPIs, antibody drug conjugations, sterile fill/finish, peptide products and services and potent solid oral drug products. PPS also provides services for biologics, including vaccines, gene therapies and monoclonal antibodies through its subsidiary Yapan Bio.
blank

10

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Carbetocin Acetate

About the Company : Established in 1997, the PRECISE Group is a respected pharmaceutical company in India with an annual turnover of USD 40 million. Backed by a skilled regulatory team, a dedicated fo...

Established in 1997, the PRECISE Group is a respected pharmaceutical company in India with an annual turnover of USD 40 million. Backed by a skilled regulatory team, a dedicated formulation and development unit, and over 100 professionals, PRECISE has emerged as a one-stop solution for APIs, intermediates, and finished formulations. Leveraging our core strengths, we continue to strengthen our presence in the global market.
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more

Details:

ACP-101 (carbetocin) is a small molecule nasal spray acting as an Oxytocin receptor agonist, it is currently being investigated for the treatment of hyperphagia in Prader-Willi syndrome.


Lead Product(s): Carbetocin Acetate

Therapeutic Area: Genetic Disease Brand Name: ACP-101

Study Phase: Phase IIIProduct Type: Peptide

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable November 30, 2023

blank

01

Arvo
Not Confirmed
Arvo
Not Confirmed

Details : ACP-101 (carbetocin) is a small molecule nasal spray acting as an Oxytocin receptor agonist, it is currently being investigated for the treatment of hyperphagia in Prader-Willi syndrome.

Product Name : ACP-101

Product Type : Peptide

Upfront Cash : Inapplicable

November 30, 2023

blank

Details:

ACP-101 (carbetocin) is an investigational drug in the form of an intranasal formulation of carbetocin being developed for the treatment of hyperphagia in Prader-Willi syndrome (PWS).


Lead Product(s): Carbetocin Acetate

Therapeutic Area: Genetic Disease Brand Name: ACP-101

Study Phase: Phase IIIProduct Type: Peptide

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable June 13, 2023

blank

02

Arvo
Not Confirmed
Arvo
Not Confirmed

Details : ACP-101 (carbetocin) is an investigational drug in the form of an intranasal formulation of carbetocin being developed for the treatment of hyperphagia in Prader-Willi syndrome (PWS).

Product Name : ACP-101

Product Type : Peptide

Upfront Cash : Inapplicable

June 13, 2023

blank

Details:

The novel, room-temperature-stable (RTS), single-dose formulation of Carbetocin will address prevailing challenges with existing protocols that require cold-chain storage and transportation.


Lead Product(s): Carbetocin Acetate

Therapeutic Area: Obstetrics/Gynecology (Women’s Health) Brand Name: Undisclosed

Study Phase: Approved FDFProduct Type: Peptide

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable August 31, 2021

blank

03

Arvo
Not Confirmed
Arvo
Not Confirmed

Details : The novel, room-temperature-stable (RTS), single-dose formulation of Carbetocin will address prevailing challenges with existing protocols that require cold-chain storage and transportation.

Product Name : Undisclosed

Product Type : Peptide

Upfront Cash : Inapplicable

August 31, 2021

blank

Details:

CARITEC® is a drug similar to oxytocin with longer duration of action. CARITEC® is indicated for the prevention of excessive bleeding in women after vaginal or caesarean child birth. The condition is commonly known as post-partum hemorrhage (PPH).


Lead Product(s): Carbetocin Acetate

Therapeutic Area: Obstetrics/Gynecology (Women’s Health) Brand Name: CARITEC

Study Phase: Approved FDFProduct Type: Peptide

Sponsor: Sun Pharmaceutical Industries Limited

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Licensing Agreement February 06, 2021

blank

04

Arvo
Not Confirmed
Arvo
Not Confirmed

Details : CARITEC® is a drug similar to oxytocin with longer duration of action. CARITEC® is indicated for the prevention of excessive bleeding in women after vaginal or caesarean child birth. The condition is commonly known as post-partum hemorrhage (PPH).

Product Name : CARITEC

Product Type : Peptide

Upfront Cash : Undisclosed

February 06, 2021

blank

Details:

While the study did not meet its primary outcome measurements evaluating the 9.6 mg dose of LV-101 statistical significance was achieved with the 3.2 mg dose as evaluated by the Hyperphagia Questionnaire for Clinical Trials score (p=0.016) as the first secondary endpoint.


Lead Product(s): Carbetocin Acetate

Therapeutic Area: Genetic Disease Brand Name: LV-101

Study Phase: Phase IIIProduct Type: Peptide

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable June 08, 2020

blank

05

Arvo
Not Confirmed
Arvo
Not Confirmed

Details : While the study did not meet its primary outcome measurements evaluating the 9.6 mg dose of LV-101 statistical significance was achieved with the 3.2 mg dose as evaluated by the Hyperphagia Questionnaire for Clinical Trials score (p=0.016) as the first s...

Product Name : LV-101

Product Type : Peptide

Upfront Cash : Inapplicable

June 08, 2020

blank

Details:

Carbetocin Ferring is the first medicine approved under the new Swissmedic and Marketing Authorisation for Global Health Products (MAGHP) procedure, which aims to build capacity and speed up access to essential medicines in low- and middle-income countries.


Lead Product(s): Carbetocin Acetate

Therapeutic Area: Obstetrics/Gynecology (Women’s Health) Brand Name: CARITEC

Study Phase: Approved FDFProduct Type: Peptide

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable May 13, 2020

blank

06

Arvo
Not Confirmed
Arvo
Not Confirmed

Details : Carbetocin Ferring is the first medicine approved under the new Swissmedic and Marketing Authorisation for Global Health Products (MAGHP) procedure, which aims to build capacity and speed up access to essential medicines in low- and middle-income countri...

Product Name : CARITEC

Product Type : Peptide

Upfront Cash : Inapplicable

May 13, 2020

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

APIs

read-more
read-more
PharmaCompass
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for 37025-55-1 / Carbetocin Acetate API manufacturers, exporters & distributors?

Carbetocin Acetate manufacturers, exporters & distributors 1

55

PharmaCompass offers a list of Carbetocin Acetate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Carbetocin Acetate manufacturer or Carbetocin Acetate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Carbetocin Acetate manufacturer or Carbetocin Acetate supplier.

PharmaCompass also assists you with knowing the Carbetocin Acetate API Price utilized in the formulation of products. Carbetocin Acetate API Price is not always fixed or binding as the Carbetocin Acetate Price is obtained through a variety of data sources. The Carbetocin Acetate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Carbetocin Acetate

Synonyms

37025-55-1, Pabal, Carbetocino, Carbetocinum, Chebi:59204, Lv-101

Cas Number

37025-55-1

Unique Ingredient Identifier (UNII)

88TWF8015Y

About Carbetocin Acetate

Carbetocin is a long-acting synthetic agonist analogue of human oxytocin, with antihemorrhagic and uterotonic activities. Upon administration, carbetocin targets, binds to and activates peripheral oxytocin receptors that are present on the smooth musculature of the uterus. This causes uterus contractions and prevents excessive bleeding after childbirth, particularly following Cesarean section, and may be used to decrease blood loss during hysteroscopic myomectomy.

Carbetocin Acetate Manufacturers

A Carbetocin Acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Carbetocin Acetate, including repackagers and relabelers. The FDA regulates Carbetocin Acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Carbetocin Acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Carbetocin Acetate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Carbetocin Acetate Suppliers

A Carbetocin Acetate supplier is an individual or a company that provides Carbetocin Acetate active pharmaceutical ingredient (API) or Carbetocin Acetate finished formulations upon request. The Carbetocin Acetate suppliers may include Carbetocin Acetate API manufacturers, exporters, distributors and traders.

click here to find a list of Carbetocin Acetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Carbetocin Acetate USDMF

A Carbetocin Acetate DMF (Drug Master File) is a document detailing the whole manufacturing process of Carbetocin Acetate active pharmaceutical ingredient (API) in detail. Different forms of Carbetocin Acetate DMFs exist exist since differing nations have different regulations, such as Carbetocin Acetate USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Carbetocin Acetate DMF submitted to regulatory agencies in the US is known as a USDMF. Carbetocin Acetate USDMF includes data on Carbetocin Acetate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Carbetocin Acetate USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Carbetocin Acetate suppliers with USDMF on PharmaCompass.

Carbetocin Acetate KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Carbetocin Acetate Drug Master File in Korea (Carbetocin Acetate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Carbetocin Acetate. The MFDS reviews the Carbetocin Acetate KDMF as part of the drug registration process and uses the information provided in the Carbetocin Acetate KDMF to evaluate the safety and efficacy of the drug.

After submitting a Carbetocin Acetate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Carbetocin Acetate API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Carbetocin Acetate suppliers with KDMF on PharmaCompass.

Carbetocin Acetate WC

A Carbetocin Acetate written confirmation (Carbetocin Acetate WC) is an official document issued by a regulatory agency to a Carbetocin Acetate manufacturer, verifying that the manufacturing facility of a Carbetocin Acetate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Carbetocin Acetate APIs or Carbetocin Acetate finished pharmaceutical products to another nation, regulatory agencies frequently require a Carbetocin Acetate WC (written confirmation) as part of the regulatory process.

click here to find a list of Carbetocin Acetate suppliers with Written Confirmation (WC) on PharmaCompass.

Carbetocin Acetate GMP

Carbetocin Acetate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Carbetocin Acetate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Carbetocin Acetate GMP manufacturer or Carbetocin Acetate GMP API supplier for your needs.

Carbetocin Acetate CoA

A Carbetocin Acetate CoA (Certificate of Analysis) is a formal document that attests to Carbetocin Acetate's compliance with Carbetocin Acetate specifications and serves as a tool for batch-level quality control.

Carbetocin Acetate CoA mostly includes findings from lab analyses of a specific batch. For each Carbetocin Acetate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Carbetocin Acetate may be tested according to a variety of international standards, such as European Pharmacopoeia (Carbetocin Acetate EP), Carbetocin Acetate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Carbetocin Acetate USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty